Impact Factor
3.68
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.29
1,467 total citations
h5-index
42
h5 depth signal
Cited share
70.9%
333 of 470
Total citations
1,467
Citation footprint
Metric signal
3.59
External metric anchor
Self-citation
5.6%
82 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United Kingdom
1,182
United States
436
Australia
366
Denmark
229
Canada
165
Citing Fields of Research
Diabetes
2,381
Obstetrics/Gynecology
242
Nutrition & Dietetics
184
Health Education & Remote Healthcare
137
Endocrinology & Metabolism
115
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
11,453
Articles tracked across the journal lifetime
Indexed publication set
470
333 cited publications
Last 12 months
332
27.7 publications/month
Open access share
57.8%
192 OA publications in the last year
Leading citing country
United Kingdom
1,182 citing publications
Leading citing field
Diabetes
2,381 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v1n1, 1984-
v1n1, 1984-
Active Coverage
Research Focus & Classification
Indexed Subjects
Diabetes
Issuing & Sponsoring Bodies
Contributor
British Diabetic Association
Broad Categories
Endocrinology
Diabetes
MeSH Descriptors
Diabetes Mellitus
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1111/dme.70500
Open DOI
Real‐world observational study evaluating metabolic and kidney outcomes in patients living with chronic kidney disease and type 2 diabetes mellitus with obesity prescribed tirzepatide
Background: Obesity and type 2 diabetes mellitus (T2DM) accelerate chronic kidney disease (CKD) progression. Tirzepatide, a dual glucagon‐like peptide‐1 (GLP‐1) and glucose‐dependent insulinotropic polypeptide (GIP) receptor agonist, has...
02
DOI 10.1111/dme.70503
Open DOI
Predictive performance of the Saint Elian Wound Score System adjusted for age for major amputation in diabetic foot: A competing risks analysis
Aims: To evaluate the prognostic performance of Saint Elian Wound Score System (SEWSS) adjusted for age in predicting major amputation (MA) in patients with diabetic foot (DF). Methods: A retrospective cohort study was conducted, includi...
03
DOI 10.1111/dme.70505
Open DOI
Islet–exocrine crosstalk in diabetes: Distinguishing whole‐pancreas pathology from causal communication
Aims: To critically evaluate how communication between the endocrine and exocrine pancreas contributes to diabetes and to distinguish whole‐pancreas involvement from mechanistically demonstrated crosstalk. Methods: We conducted a narrati...
04
DOI 10.1111/dme.70504
Open DOI
Key safety outcomes of SGLT2 inhibitors versus DPP ‐4 inhibitors in general and vulnerable participants with T2DM : A target trial emulation study
Aims: Sodium–glucose cotransporter‐2 inhibitors (SGLT2i), a class of oral hypoglycaemic agents (OHAs), have demonstrated cardiovascular and renal benefits. However, safety concerns may hinder their broader adoption, particularly among fr...
05
DOI 10.1111/dme.70509
Open DOI
New insights into β‐cell vulnerability in type 1 diabetes—Lessons from nature
Type 1 diabetes results from an autoimmune‐mediated destruction of pancreatic β‐cells, yet considerable heterogeneity exists regarding disease onset, progression and severity. Emerging evidence suggests that this variability reflects not...
06
DOI 10.1111/dme.70501
Open DOI
What do administrative diabetes indicators measure? Treatment‐side and screening‐side evidence from nationwide NDB Open Data in Japan
Aims: Regional administrative diabetes indicators are increasingly used for population surveillance and planning, yet they are generated through the healthcare system rather than measuring disease directly. We examined what two complemen...
07
DOI 10.1111/dme.70487
Open DOI
Physical activity and sleep patterns in women 1 year after gestational diabetes: Results from the Face‐it study
Aims: Moderate‐to‐vigorous physical activity (MVPA) and adequate, high‐quality sleep are important for cardiometabolic health in women with recent gestational diabetes mellitus (GDM) but are likely reduced during early motherhood. These ...
08
DOI 10.1111/dme.70502
Open DOI
Issue Information
09
10
Aims: The National Health Service (NHS) offers Healthy Living , an online Diabetes Self‐Management Education and Support service, to help people Self Manage Type 2 Diabetes, with modest 1‐year reductions in HbA1c levels, systolic blood p...
Bibliographical & Catalog Notes
Title from cover.
Imprint varies.
Has supplement: Innovative care.
Also issued online.
Vol. 7, no. 2 (FEB 1990)19900917 Notice not published Printed on acid-free paper